Groupe la Francaise »

Apogee Therapeutics shares owned by Groupe la Francaise

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Groupe la Francaise from 13F filings

Historical chart of Groupe la Francaise investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Groupe la Francaise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Groupe la Francaise

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 84k 132.73

More positions owned by Groupe la Francaise

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Totalenergies Se Act (TTE)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Astrazeneca Ord (AZN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Cgi Cl A Sub Vtg (GIB)

View all positions for Groupe la Francaise

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
HBK Investments
Vanguard Capital Management
FMR
Henderson Group
Balyasny Asset Management
State Street Corporation
Driehaus Capital Management
Goldman Sachs Group
Glazer Capital
Paradigm Biocapital Advisors
Vanguard Portfolio Management
Millennium Management
Pentwater Capital Management

View all funds holding Apogee Therapeutics